Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-05-02

FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for sirolimus submitted by Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus (Sirolimus)

Snippet

SUPPL AP for SIROLIMUS (SIROLIMUS)